OrderlyMeds releases "GLP-1's & Nutrition: The Refresh," a webinar led by dietitian Kirstin Kirkpatrick, MS RDN, providing evidence-based nutrition strategies for individuals using GLP-1 medications for weight management.
-- OrderlyMeds has released "GLP-1's & Nutrition: The Refresh," a webinar resource that addresses a critical knowledge gap for individuals navigating weight management with GLP-1 medications. This educational tool combines recent research on how these medications affect metabolism and appetite with actionable nutrition strategies, offering evidence-based guidance tailored to the unique needs of GLP-1 users who often struggle to find reliable dietary information during treatment.
More information is available at https://orderlymeds.com/resources/resource-webinar/glp1-nutrition-webinar/
As GLP-1 medications gain widespread adoption for weight management, users face complex nutritional challenges that extend beyond simple calorie reduction. These medications alter appetite regulation and metabolic processes in ways that require specialized dietary approaches, while emerging research continues to examine their broader health implications beyond weight loss, including potential connections to cancer risk, addiction pathways, and dementia prevention. The growing body of evidence underscores the need for expert-led educational resources that help patients optimize their nutrition while using these therapeutic tools, the team explains.
OrderlyMeds has enlisted Kirstin Kirkpatrick, MS RDN, to lead its nutrition-focused educational initiatives. She brings more than 20 years of clinical experience to the development of webinar content, including a tenure at Cleveland Clinic, where she developed expertise in translating complex nutritional science into practical patient guidance. By partnering with a credentialed professional who has spent decades in clinical settings, OrderlyMeds ensures that its educational materials reflect current evidence rather than generic dietary advice.
The webinar addresses specific nutritional priorities for individuals using GLP-1 medications, with particular emphasis on protein intake and fiber consumption. Clinical recommendations suggest a minimum protein target of 1 gram per kilogram of body weight to preserve muscle mass during the weight loss process, translating to approximately 80 to 100 grams daily for most women. Adequate fiber intake also plays a role in managing common side effects such as constipation, which many GLP-1 users experience. These evidence-based recommendations provide concrete benchmarks that help patients structure their daily eating patterns to support both weight loss goals and overall metabolic health.
Individuals currently using or considering GLP-1 medications who seek expert-backed nutrition guidance can access the webinar through OrderlyMeds' online platform. For more details, visit https://orderlymeds.com/
Contact Info:
Name: Annie Dawson
Email: Send Email
Organization: OrderlyMeds
Address: 235 Ponce De Leon Pl Suite M347, Decatur, Georgia 30030, United States
Website: https://orderlymeds.com/
Source: PressCable
Release ID: 89195262
If you come across any problems, discrepancies, or concerns related to the content contained within this press release that necessitate action or if a press release requires takedown, we strongly encourage you to reach out without delay by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will be readily accessible round-the-clock to address your concerns within 8 hours and take appropriate actions to rectify identified issues or support with press release removals. Ensuring accurate and reliable information remains our unwavering commitment.
